Craft

BCAL Diagnostics

Stock Price

$0.1

2024-10-22

BCAL Diagnostics Summary

Company Summary

Overview
BCAL Diagnostics is a biotechnology company that engages in laboratory blood tests for the detection of breast cancer. It offers tests including BCAL, lipid biomarker blood, screening, monitoring, and invitro diagnostic., which confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient's body, etc.
Type
Public
Status
Active
Founded
2010
Website
https://www.bcaldiagnostics.com/
Cybersecurity rating
Sectors

Table of Contents

Footer menu